Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChemPartner, the operating brand of Shanghai RuiZhi Pharmaceutical, is a global leader in providing integrated drug discovery and development services. Established in 2003, the company functions as a comprehensive CRO and CDMO, supporting clients from early-stage lead generation through to clinical manufacturing. Their service portfolio includes discovery chemistry, biology, pharmacology, DMPK, and biologics discovery and development. With a significant presence in Shanghai and satellite operations in the United States and Europe, ChemPartner serves a diverse global clientele ranging from virtual biotechs to large pharmaceutical corporations. The company is distinguished by its specialized technology platforms and its ability to provide end-to-end solutions for both small molecule and large molecule therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai RuiZhi Pharmaceutical.